Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Prognostic and Long-term Survival of Immune Thrombotic Thrombocytopenic Purpura in older patients.

Prevel R, Roubaud-Roubaud C, Gourlain S, Jamme M, Peres K, Benhamou Y, Galicier L, Azoulay E, Poullin P, Provôt F, Maury E, Presne C, Hamidou M, Saheb S, Wynckel A, Servais A, Girault S, Delmas Y, Chatelet V, Augusto JF Sr, Mousson C, Perez P, Halimi JM, Kanouni T, Lautrette A, Charvet Rumpler A, Deligny C, Chauveau D, Veyradier A Pr, Coppo P.

Blood. 2019 Sep 17. pii: blood.2019000748. doi: 10.1182/blood.2019000748. [Epub ahead of print]

PMID:
31530564
2.

Efficacy and safety of plasma exchange using a double viral inactivated and prion reduced solvent/detergent fresh frozen plasma for the treatment of thrombotic microangiopathy: The first French experience in a single center.

Poullin P, Delmotte N, Sanderson F, Roche M, Gensollen S.

Transfus Apher Sci. 2019 Jul 9. pii: S1473-0502(19)30118-1. doi: 10.1016/j.transci.2019.07.002. [Epub ahead of print]

PMID:
31331708
3.

Caplacizumab to treat immune-mediated thrombotic thrombocytopenic purpura.

Poullin P, Bornet C, Veyradier A, Coppo P.

Drugs Today (Barc). 2019 Jun;55(6):367-376. doi: 10.1358/dot.2019.55.6.2989843. Review.

PMID:
31250841
4.

Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort.

Daviet F, Rouby F, Poullin P, Moussi-Francès J, Sallée M, Burtey S, Mancini J, Duffaud F, Sabatier R, Pourroy B, Grandvuillemin A, Grange S, Frémeaux-Bacchi V, Coppo P, Micallef J, Jourde-Chiche N.

Br J Clin Pharmacol. 2019 Feb;85(2):403-412. doi: 10.1111/bcp.13808. Epub 2018 Dec 18.

PMID:
30394581
5.

Cladribine-related immunosuppression may have fostered graft-versus-host disease after lung transplant for pulmonary Langerhans cell histiocytosis.

Galambrun C, Garaix F, Ughetto F, Picard C, Petit P, Bosdure E, Poullin P, Stremler N, Mace L, Donadieu J.

Pediatr Blood Cancer. 2019 Jan;66(1):e27477. doi: 10.1002/pbc.27477. Epub 2018 Sep 30. No abstract available.

PMID:
30270491
6.

Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura.

Jestin M, Benhamou Y, Schelpe AS, Roose E, Provôt F, Galicier L, Hié M, Presne C, Poullin P, Wynckel A, Saheb S, Deligny C, Servais A, Girault S, Delmas Y, Kanouni T, Lautrette A, Chauveau D, Mousson C, Perez P, Halimi JM, Charvet-Rumpler A, Hamidou M, Cathébras P, Vanhoorelbeke K, Veyradier A, Coppo P; French Thrombotic Microangiopathies Reference Center.

Blood. 2018 Nov 15;132(20):2143-2153. doi: 10.1182/blood-2018-04-840090. Epub 2018 Sep 10.

PMID:
30201758
7.

Hematopoietic reconstitution after autologous hematopoietic stem cell transplantation: do CD45 (+) CD34 (+) CD38 (-) progenitors really matter in real life?

Venton G, Suchon P, Colle J, Baier C, Sanderson F, Poullin P, Ivanov V, Mercier C, Farnault L, Roche P, Arcani R, Fanciullino R, Brunet C, Philip PJM, Costello R.

Transfus Apher Sci. 2018 Jun;57(3):406-408. doi: 10.1016/j.transci.2018.04.021. Epub 2018 Apr 24. No abstract available.

PMID:
29709543
8.

Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: Causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centre.

Grall M, Azoulay E, Galicier L, Provôt F, Wynckel A, Poullin P, Grange S, Halimi JM, Lautrette A, Delmas Y, Presne C, Hamidou M, Girault S, Pène F, Perez P, Kanouni T, Seguin A, Mousson C, Chauveau D, Ojeda-Uribe M, Barbay V, Veyradier A, Coppo P, Benhamou Y.

Am J Hematol. 2017 Apr;92(4):381-387. doi: 10.1002/ajh.24665. Epub 2017 Feb 21.

9.

Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: Results of a phase II, multicenter noncomparative study.

Benhamou Y, Paintaud G, Azoulay E, Poullin P, Galicier L, Desvignes C, Baudel JL, Peltier J, Mira JP, Pène F, Presne C, Saheb S, Deligny C, Rousseau A, Féger F, Veyradier A, Coppo P; French Reference Center for Thrombotic Microangiopathies.

Am J Hematol. 2016 Dec;91(12):1246-1251. doi: 10.1002/ajh.24559. Epub 2016 Nov 8.

10.

Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors.

Venton G, Pérez-Alea M, Baier C, Fournet G, Quash G, Labiad Y, Martin G, Sanderson F, Poullin P, Suchon P, Farnault L, Nguyen C, Brunet C, Ceylan I, Costello RT.

Blood Cancer J. 2016 Sep 9;6(9):e469. doi: 10.1038/bcj.2016.78.

11.

Peripheral blood stem cells collection on spectra optia apheresis system using the continuous mononuclear cell collection protocol: A single center report of 39 procedures.

Sanderson F, Poullin P, Smith R, Nicolino-Brunet C, Philip P, Chaib A, Costello R.

J Clin Apher. 2017 Jun;32(3):182-190. doi: 10.1002/jca.21485. Epub 2016 Jul 21.

PMID:
27442837
12.

Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.

Mariotte E, Azoulay E, Galicier L, Rondeau E, Zouiti F, Boisseau P, Poullin P, de Maistre E, Provôt F, Delmas Y, Perez P, Benhamou Y, Stepanian A, Coppo P, Veyradier A; French Reference Center for Thrombotic Microangiopathies.

Lancet Haematol. 2016 May;3(5):e237-45. doi: 10.1016/S2352-3026(16)30018-7. Epub 2016 Apr 16.

PMID:
27132698
13.

Risk Factors for Autoimmune Diseases Development After Thrombotic Thrombocytopenic Purpura.

Roriz M, Landais M, Desprez J, Barbet C, Azoulay E, Galicier L, Wynckel A, Baudel JL, Provôt F, Pène F, Mira JP, Presne C, Poullin P, Delmas Y, Kanouni T, Seguin A, Mousson C, Servais A, Bordessoule D, Perez P, Chauveau D, Veyradier A, Halimi JM, Hamidou M, Coppo P; French Thrombotic Microangiopathies Reference Center.

Medicine (Baltimore). 2015 Oct;94(42):e1598. doi: 10.1097/MD.0000000000001598.

14.

Comparative evaluation of the depletion-red cell exchange program with the Spectra Optia and the isovolemic hemodilution-red cell exchange method with the COBE Spectra in sickle cell disease patients.

Poullin P, Sanderson F, Bernit E, Brun M, Berdah Y, Badens C.

J Clin Apher. 2016 Oct;31(5):429-33. doi: 10.1002/jca.21422. Epub 2015 Aug 14.

PMID:
26274351
15.

Are platelet transfusions harmful in acquired thrombotic thrombocytopenic purpura at the acute phase? Experience of the French thrombotic microangiopathies reference center.

Benhamou Y, Baudel JL, Wynckel A, Galicier L, Azoulay E, Provôt F, Pène F, Mira JP, Presne C, Poullin P, Halimi JM, Rivière E, Kanouni T, Seguin A, Mousson C, Servais A, Bordessoule D, Perez P, Hamidou M, Chauveau D, Veyradier A, Coppo P.

Am J Hematol. 2015 Jun;90(6):E127-9. doi: 10.1002/ajh.23997. No abstract available.

16.

Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center.

Benhamou Y, Boelle PY, Baudin B, Ederhy S, Gras J, Galicier L, Azoulay E, Provôt F, Maury E, Pène F, Mira JP, Wynckel A, Presne C, Poullin P, Halimi JM, Delmas Y, Kanouni T, Seguin A, Mousson C, Servais A, Bordessoule D, Perez P, Hamidou M, Cohen A, Veyradier A, Coppo P; Reference Center for Thrombotic Microangiopathies.

J Thromb Haemost. 2015 Feb;13(2):293-302. doi: 10.1111/jth.12790. Epub 2014 Dec 18.

17.

Circulating endothelial cells and progenitors as prognostic factors during autoimmune thrombotic thrombocytopenic purpura: results of a prospective multicenter French study.

Widemann A, Pasero C, Arnaud L, Poullin P, Loundou AD, Choukroun G, Sanderson F, Lacroix R, Sabatier F, Coppo P, Dignat-George F, Kaplanski G; ENDO-13 study group.

J Thromb Haemost. 2014 Oct;12(10):1601-9. doi: 10.1111/jth.12681. Epub 2014 Sep 22.

18.

Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura.

Hie M, Gay J, Galicier L, Provôt F, Presne C, Poullin P, Bonmarchand G, Wynckel A, Benhamou Y, Vanhille P, Servais A, Bordessoule D, Coindre JP, Hamidou M, Vernant JP, Veyradier A, Coppo P; French Thrombotic Microangiopathies Reference Centre.

Blood. 2014 Jul 10;124(2):204-10. doi: 10.1182/blood-2014-01-550244. Epub 2014 May 28.

PMID:
24869941
19.

High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference Center.

Morgand M, Buffet M, Busson M, Loiseau P, Malot S, Amokrane K, Fortier C, London J, Bonmarchand G, Wynckel A, Provôt F, Poullin P, Vanhille P, Presne C, Bordessoule D, Girault S, Delmas Y, Hamidou M, Mousson C, Vigneau C, Lautrette A, Pourrat J, Galicier L, Azoulay E, Pène F, Mira JP, Rondeau E, Ojeda-Uribe M, Charron D, Maury E, Guidet B, Veyradier A, Tamouza R, Coppo P; Thrombotic Microangiopathies Reference Center.

Transfusion. 2014 Feb;54(2):389-97. doi: 10.1111/trf.12263. Epub 2013 May 27.

PMID:
23711330
20.

Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis.

Lacroix R, Plawinski L, Robert S, Doeuvre L, Sabatier F, Martinez de Lizarrondo S, Mezzapesa A, Anfosso F, Leroyer AS, Poullin P, Jourde N, Njock MS, Boulanger CM, Anglés-Cano E, Dignat-George F.

Haematologica. 2012 Dec;97(12):1864-72. doi: 10.3324/haematol.2012.066167. Epub 2012 Jun 24.

21.

Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.

Benhamou Y, Assié C, Boelle PY, Buffet M, Grillberger R, Malot S, Wynckel A, Presne C, Choukroun G, Poullin P, Provôt F, Gruson D, Hamidou M, Bordessoule D, Pourrat J, Mira JP, Le Guern V, Pouteil-Noble C, Daubin C, Vanhille P, Rondeau E, Palcoux JB, Mousson C, Vigneau C, Bonmarchand G, Guidet B, Galicier L, Azoulay E, Rottensteiner H, Veyradier A, Coppo P; Thrombotic Microangiopathies Reference Center.

Haematologica. 2012 Aug;97(8):1181-6. Epub 2012 May 11.

22.

[Effectiveness of therapeutic erythrocytapheresis to achieve iron depletion in hereditary type 1 hemochromatosis: report of 30 cases].

Poullin P, Lefèvre PA.

Transfus Clin Biol. 2011 Dec;18(5-6):553-8. doi: 10.1016/j.tracli.2011.04.004. Epub 2011 Oct 22. French.

PMID:
22019606
23.

Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.

Froissart A, Buffet M, Veyradier A, Poullin P, Provôt F, Malot S, Schwarzinger M, Galicier L, Vanhille P, Vernant JP, Bordessoule D, Guidet B, Azoulay E, Mariotte E, Rondeau E, Mira JP, Wynckel A, Clabault K, Choukroun G, Presne C, Pourrat J, Hamidou M, Coppo P; French Thrombotic Microangiopathies Reference Center.

Crit Care Med. 2012 Jan;40(1):104-11. doi: 10.1097/CCM.0b013e31822e9d66.

PMID:
21926591
24.

Stroke in a young patient treated by alteplase heralding an acquired thrombotic thrombocytopenic purpura.

Sevy A, Doche E, Squarcioni C, Poullin P, Serratrice J, Nicoli F, Weiller PJ.

J Clin Apher. 2011;26(3):152-5. doi: 10.1002/jca.20276. Epub 2010 Dec 13.

PMID:
21647953
25.

Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience.

Coppo P, Schwarzinger M, Buffet M, Wynckel A, Clabault K, Presne C, Poullin P, Malot S, Vanhille P, Azoulay E, Galicier L, Lemiale V, Mira JP, Ridel C, Rondeau E, Pourrat J, Girault S, Bordessoule D, Saheb S, Ramakers M, Hamidou M, Vernant JP, Guidet B, Wolf M, Veyradier A; French Reference Center for Thrombotic Microangiopathies.

PLoS One. 2010 Apr 23;5(4):e10208. doi: 10.1371/journal.pone.0010208.

26.

HLA-DRB1*11: a strong risk factor for acquired severe ADAMTS13 deficiency-related idiopathic thrombotic thrombocytopenic purpura in Caucasians.

Coppo P, Busson M, Veyradier A, Wynckel A, Poullin P, Azoulay E, Galicier L, Loiseau P; French Reference Centre For Thrombotic Microangiopathies.

J Thromb Haemost. 2010 Apr;8(4):856-9. doi: 10.1111/j.1538-7836.2010.03772.x. Epub 2010 Feb 6. No abstract available.

27.

Thrombotic thrombocytopenic purpura complicating interferon therapy in chronic C hepatitis.

Sallée M, Crétel E, Jean R, Chiche L, Bourlière M, Poullin P, Lefèvre P, Durand JM.

Gastroenterol Clin Biol. 2008 Feb;32(2):145-6. No abstract available.

28.

[Therapeutic erythrocytapheresis: technical aspects and clinical applications].

Poullin P, Lefèvre P.

Rev Med Interne. 2008 Apr;29(4):290-6. doi: 10.1016/j.revmed.2007.10.406. Epub 2007 Nov 20. Review. French.

PMID:
18280010
29.

[Update on thrombotic thrombocytopenic purpura].

Schleinitz N, Poullin P, Camoin L, Veit V, Bernit E, Mazodier K, Lefèvre P, Dignat-George F, Kaplanski G, Durand JM, Harlé JR.

Rev Med Interne. 2008 Oct;29(10):794-800. Epub 2007 Oct 22. Review. French.

PMID:
18023939
30.

Rituximab as preventive therapy of a clinical relapse in TTP with ADAMTS13 inhibitor.

Schleinitz N, Ebbo M, Mazodier K, Poullin P, Bernit E, Veit V, Veyradier A, Fakhouri F, Kaplanski G, Harle JR.

Am J Hematol. 2007 May;82(5):417-8. No abstract available.

31.

Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity.

Ferrari S, Scheiflinger F, Rieger M, Mudde G, Wolf M, Coppo P, Girma JP, Azoulay E, Brun-Buisson C, Fakhouri F, Mira JP, Oksenhendler E, Poullin P, Rondeau E, Schleinitz N, Schlemmer B, Teboul JL, Vanhille P, Vernant JP, Meyer D, Veyradier A; French Clinical and Biological Network on Adult Thrombotic Microangiopathies.

Blood. 2007 Apr 1;109(7):2815-22.

PMID:
17164349
32.

[Paediatric case report of an acquired autoimmune thrombotic thrombocytopenic purpura].

Curtillet C, Poullin P, Doré E, Fossat C, Lefevre P, Michel G.

Arch Pediatr. 2006 Dec;13(12):1521-4. Epub 2006 Sep 28. French.

PMID:
17010579
33.

Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases.

Fakhouri F, Vernant JP, Veyradier A, Wolf M, Kaplanski G, Binaut R, Rieger M, Scheiflinger F, Poullin P, Deroure B, Delarue R, Lesavre P, Vanhille P, Hermine O, Remuzzi G, Grünfeld JP.

Blood. 2005 Sep 15;106(6):1932-7. Epub 2005 Jun 2.

PMID:
15933059
34.

Protein A-immunoadsorption (Prosorba column) in the treatment of rheumatoid arthritis.

Poullin P, Announ N, Mugnier B, Guis S, Roudier J, Lefèvre P.

Joint Bone Spine. 2005 Mar;72(2):101-3. Review. No abstract available.

PMID:
15797486
35.

Severe hemolytic anemia due to cold agglutinin complicating untreated chronic hepatitis C: efficacy and safety of anti-CD20 (rituximab) treatment.

Etienne A, Gayet S, Vidal F, Poullin P, Brunet C, Harlé JR, Kaplanski G.

Am J Hematol. 2004 Apr;75(4):243-5.

36.

Clinical improvement in a patient with severe rheumatoid arthritis and chronic hepatitis B after prosorba column immunoadsorption: a one-year followup.

Mugnier B, Poullin P, Lefevre P, Roudier J.

Arthritis Rheum. 2003 Oct 15;49(5):722-3. No abstract available.

37.

Autoimmune thrombotic thrombocytopenic purpura: a severe complication of inflammatory bowel disease.

Schleinitz N, Faure V, Bernit E, Veit V, Harlé JR, Poullin P, Lefevre P, Jego-Desplat S.

J Clin Gastroenterol. 2003 Jan;36(1):83-4. No abstract available.

PMID:
12488721
38.

[Extracorporeal photochemotherapy in therapy-refractory subacute lupus].

Richard MA, Saadallah S, Lefevre P, Poullin P, Buscaylet S, Grob JJ.

Ann Dermatol Venereol. 2002 Aug-Sep;129(8-9):1023-6. French.

PMID:
12442100
39.

[Pemphigoid and acquired hemophilia].

Lightburn E, Morand JJ, Graffin B, Molinier S, Raphenon G, Poullin P, Harlé JR, Chouc C.

Ann Dermatol Venereol. 2001 Nov;128(11):1229-31. French.

PMID:
11908168
40.

[Idiopathic thrombotic thrombocytopenic purpura or Moschowitz syndrome: current physiopathologic and therapeutic perspectives].

Retornaz F, Durand JM, Poullin P, Lefèvre P, Soubeyrand J.

Rev Med Interne. 2000 Sep;21(9):777-84. Review. French.

PMID:
11039173
41.

Mixed connective tissue disease with hemolytic anemia and severe thrombocytopenia due to thrombotic thrombocytopenic purpura.

Poullin P, Lefevre P, Durand JM.

Am J Hematol. 1999 Aug;61(4):275. No abstract available.

42.

[Heparin-induced thrombopenia: rapid regression of thrombopenia and thrombosis after plasma exchange. Case report].

Poullin P, Pietri PA, Lefèvre P.

Rev Med Interne. 1998 Nov;19(11):819-22. French.

PMID:
9864780
43.

Heparin-induced thrombocytopenia with thrombosis: successful treatment with plasma exchange.

Poullin P, Pietri PA, Lefèvre P.

Br J Haematol. 1998 Jul;102(2):630-1. No abstract available.

PMID:
9695986
44.

[Renal complications from intravenous immunoglobulins. Role of renal hemodynamic factors].

Poullin P, Moulin B, Ollier J, Benaicha M, Olmer M, Gabriel B.

Presse Med. 1995 Mar 4;24(9):441-4. Review. French.

PMID:
7746817
45.

[Apropos of 2 cases of severe malaria contracted in the port of Marseille].

Delmont J, Brouqui P, Poullin P, Pouymayou C, Faugere B, Ottomani A, Gabriel B, Bourgeade A.

Bull Soc Pathol Exot. 1995 Mar;88(4):170-3. French.

PMID:
8640079
46.

[Diabetes insipidus disclosing metastasis of breast adenocarcinoma].

Poullin P, di Costanzo V, Le Pommelet C, Gabriel B.

Rev Med Interne. 1995;16(6):444-6. French.

PMID:
7652228
47.

Thrombocytopenic purpura after recombinant hepatitis B vaccine.

Poullin P, Gabriel B.

Lancet. 1994 Nov 5;344(8932):1293. No abstract available.

PMID:
7967998
48.

Harbour-acquired Plasmodium falciparum malaria.

Delmont J, Brouqui P, Poullin P, Bourgeaade A.

Lancet. 1994 Jul 30;344(8918):330-1. No abstract available.

PMID:
7914271
49.

[Anemia revealing jejuno-ileal metastasis of cancer of the kidney].

Poullin P, Campan P, Gabriel B.

Presse Med. 1994 Jun 18;23(23):1094. French. No abstract available.

PMID:
7971824
50.

[Primary myelofibrosis and osteolytic lesions].

Poullin P, Gabriel B.

Rev Rhum Ed Fr. 1994;61(7-8):560-2. French. No abstract available.

PMID:
7833895

Supplemental Content

Loading ...
Support Center